1. Vitamin D (1, 25(OH)2D3) induces α-1-antitrypsin synthesis by CD4+ T cells, which is required for 1, 25(OH)2D3-driven IL-10. Issue 189 (May 2019) Authors: Dimeloe, Sarah; Rice, Louise V.; Chen, Hebe; Cheadle, Charlotte; Raynes, John; Pfeffer, Paul; Lavender, Paul; Richards, David F.; Nyon, Mun Peak; McDonnell, James M.; Kemper, Claudia; Gooptu, Bibek; Hawrylowicz, Catherine M. Journal: Journal of steroid biochemistry and molecular biology Issue: Issue 189(2019) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19. Issue 4 (9th July 2021) Authors: Koenis, Duco Steven; Beegun, Issa; Jouvene, Charlotte Camille; Aguirre, Gabriel Amador; Souza, Patricia Regina; Gonzalez-Nunez, Maria; Ly, Lucy; Pistorius, Kimberly; Kocher, Hemant M.; Ricketts, William; Thomas, Gavin; Perretti, Mauro; Alusi, Ghassan; Pfeffer, Paul; Dalli, Jesmond Journal: Circulation research Issue: Volume 129:Issue 4(2021) Page Start: e54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Issue 11 (November 2021) Authors: Evans, Rachael A; McAuley, Hamish; Harrison, Ewen M; Shikotra, Aarti; Singapuri, Amisha; Sereno, Marco; Elneima, Omer; Docherty, Annemarie B; Lone, Nazir I; Leavy, Olivia C; Daines, Luke; Baillie, J Kenneth; Brown, Jeremy S; Chalder, Trudie; De Soyza, Anthony; Diar Bakerly, Nawar; Easom, Nicholas... Journal: Lancet Issue: Volume 9:Issue 11(2021) Page Start: 1275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10325 (12th February 2022) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abdallah, Nabeel; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Basir; Abdul Rasheed, Althaf; Abdulakeem, Ajibode; Abdul-Kadir, Rezan; Abdullah, Abdullah; Abdulmumeen, Abdu... Journal: Lancet Issue: Volume 399:Issue 10325(2022) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development, deployment and evaluation of digitally enabled, remote, supported rehabilitation for people with long COVID-19 (Living With COVID-19 Recovery): protocol for a mixed-methods study. Issue 2 (7th February 2022) Authors: Murray, Elizabeth; Goodfellow, Henry; Bindman, Julia; Blandford, Ann; Bradbury, Katherine; Chaudhry, Tahreem; Fernandez-Reyes, Delmiro; Gomes, Manuel; Hamilton, Fiona L; Heightman, Melissa; Henley, William; Hurst, John R; Hylton, Hannah; Linke, Stuart; Pfeffer, Paul; Ricketts, William; Robson, Ch... Journal: BMJ open Issue: Volume 12:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10285 (1st May 2021) Authors: Abani, Obbina; Abbas, Ali; Abbas, Fatima; Abbas, Mustafa; Abbasi, Sadia; Abbass, Hakam; Abbott, Alfie; Abdallah, Nabeel; Abdelaziz, Ashraf; Abdelfattah, Mohamed; Abdelqader, Bushra; Abdul, Basir; Abdul Rasheed, Althaf; Abdulakeem, Ajibode; Abdul-Kadir, Rezan; Abdulmumeen, Abdulfatahi; Abdul-Rahee... Journal: Lancet Issue: Volume 397:Issue 10285(2021) Page Start: 1637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT). (7th September 2022) Authors: Jolliffe, David A; Holt, Hayley; Greenig, Matthew; Talaei, Mohammad; Perdek, Natalia; Pfeffer, Paul; Vivaldi, Giulia; Maltby, Sheena; Symons, Jane; Barlow, Nicola L; Normandale, Alexa; Garcha, Rajvinder; Richter, Alex G; Faustini, Sian E; Orton, Christopher; Ford, David; Lyons, Ronan A; Davies, G... Journal: BMJ Issue: Volume 378(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Benefits of specialist severe asthma management: demographic and geographic disparities. Issue 6 (15th December 2022) Authors: Redmond, Charlene; Heaney, Liam G.; Chaudhuri, Rekha; Jackson, David J.; Menzies-Gow, Andrew; Pfeffer, Paul; Busby, John Journal: European respiratory journal Issue: Volume 60:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Case of paradoxical adverse response to mepolizumab with mepolizumab-induced alopecia in severe eosinophilic asthma. Issue 2 (20th February 2020) Authors: Nixon, Rodanthe; Despiney, Raquel; Pfeffer, Paul Journal: BMJ case reports Issue: Volume 13:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial. Issue 3 (March 2021) Authors: Harrison, Tim W; Chanez, Pascal; Menzella, Francesco; Canonica, Giorgio Walter; Louis, Renaud; Cosio, Borja G; Lugogo, Njira L; Mohan, Arjun; Burden, Annie; McDermott, Lawrence; Garcia Gil, Esther; Zangrilli, James G; Pohl, Wolfgang; Voves, Robert; Deschampheleire, Maud; Louis, Renaud; Martinot, ... Journal: Lancet Issue: Volume 9:Issue 3(2021) Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗